Results 71 to 80 of about 3,003 (174)

Hirudin in the treatment of arterial and venous thrombotic diseases: a new perspective

, 1993
The first description of the anticoagulant action of a water-soluble, heat-resistant substance derived from the salivary glands of leeches (Hirudo medicinales) dates back to 1884. This substance was later called hirudin in 1904.
Büller, H. R.
core  

CO50 | Diagnostic accuracy of the heparin-induced multiple electrode aggregometry (HIMEA) functional test for heparin-induced thrombocytopenia

Bleeding, Thrombosis and Vascular Biology
Background and Aims: Heparin-Induced Thrombocytopenia (HIT) is a clinical syndrome that may cause thrombotic complications in patients receiving heparin therapy.
doaj   +1 more source

Regulated inhibition of coagulation by porcine endothelial cells expressing P-selectin-tagged hirudin and tissue factor pathway inhibitor fusion proteins

, 1999
Background. Thrombotic vascular occlusion resulting in infarction occurs during hyperacute rejection of allografts transplanted into sensitized patients and remains a major problem in experimental xenotransplantation.
Lechler, RI, Chen, DX, Dorling, Anthony,, Dorling, Anthony, Lechler, Robert I.,, Riesbeck, K, Dorling, A, Kemball-Cook, Geoffrey,, Tuddenham, EGD, Kemball-Cook, G, Lechler, Robert I., Chen, Daxin, Tuddenham, Edward G.D., Chen, Daxin,, Kemball-Cook, Geoffrey, McVey, John H., Tuddenham, Edward G.D.,, Riesbeck, Kristian,, Lund University., McVey, John H.,, Riesbeck, Kristian, McVey, JH   +21 more
core   +1 more source

Leech Therapy - A unique treatment in Ayurveda

, 2019
As mentioned in Ayurveda, Rakta itself is life for human being. If it get vitiated (impure) by means of unhealthy food habits and seasonal change is going to induce many disease.
Dr. Prasadshakti G. Gannur
core   +1 more source

Antithrombotic Therapy during and after Intracoronary Stenting

, 2000
Objective: To evaluate the impact on patient outcomes of antithrombotic therapy during and after intracoronary stenting. Data Sources: A MEDLINE search (1966-July 2000) for English-language clinical trials and review articles using the search terms stent
Chad A Panning
core   +1 more source

Heparin vs recombinant hirudin for anticoagulation in continuous renal replacement therapy [PDF]

Critical Care, 2000
Vargas Hein, O, v Heymann, C, Nissen, J, Lips, M, Welte, M, Kox, WJ, Spies, C   +6 more
openaire   +1 more source

Gene therapy for arterial thrombosis

, 1997
Conventional antithrombotic treatments with antiplatelet, anticoagulant or fibrinolytic drugs are not uniformly successful and are associated with hemorrhagic side effects.
Vassalli, G., Dichek, D. A.
core   +1 more source

Effective Use of BCH-2763, a New Potent Injectable Direct Thrombin Inhibitor, in Combination with Tissue Plasminogen Activator (tPA) in a Rat Arterial Thrombolysis Model

, 1998
SummaryCurrent therapeutic use of heparin as an adjunct to thrombolytic therapy for myocardial infarction is suboptimal with respect to efficacy and bleeding risk.
Peter Winocour, Carolyn Finkle, Isabelle Deschênes   +2 more
core   +1 more source

Recombinant hirudin (lepirudin) for the improvement of thrombolysis with streptokinase in patients with acute myocardial infarction Results of the HIT-4 trial

, 1999
OBJECTIVESThe purpose of this study was to compare recombinant hirudin and heparin as adjuncts to streptokinase thrombolysis in patients with acute myocardial infarction (AMI).BACKGROUNDExperimental studies and previous small clinical trials suggest that
Schröder, Rolf, Grollier, Gilles M, Molhoek, G.Peter, Karl-Ludwig Neuhaus, Gilles M Grollier, Dirk J.A Lok, Camez, Anne, Ulrich Tebbe, Holger Kuckuck, Uwe Zeymer, Peter Lazarus, Wegscheider, Karl, Laarman, G.Jan, G.Jan Laarman, Kuckuck, Holger, Lazarus, Peter, Zeymer, Uwe, Anne Camez, Tebbe, Ulrich, Rolf Schröder, Karl Wegscheider, Neuhaus, Karl-Ludwig, Lok, Dirk J.A, G.Peter Molhoek   +23 more
core   +1 more source

Datasheet1_Malignant atrophic papulosis treated with eculizumab and hirudin: a fatal case report and literature review.pdf

BackgroundMalignant atrophic papulosis (MAP) is a rare obliterative vasculopathy whose etiology and pathophysiological mechanisms remain unknown, and the treatment is still empirical. It can involve multiple systems, especially the gastrointestinal tract
Xiaodan Tang (4391692), Zhengji Song (18267421), Xueru Zhao (8040467), Linna Yu (18267418), Yun Wang (32846)   +4 more
core   +1 more source